Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network
急性肺损伤的预防和早期治疗临床试验网络
基本信息
- 批准号:8707118
- 负责人:
- 金额:$ 14.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-17 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAdult Respiratory Distress SyndromeAffectBiologicalClinicalClinical DataClinical TrialsClinical Trials NetworkCollectionData AnalysesData CollectionData QualityDevicesEarly treatmentGenderGenerationsGeneticGenomicsGoalsHospitalsLeadershipMethodsMorbidity - disease rateNational Heart, Lung, and Blood InstituteOutcomePatient RecruitmentsPatientsPneumoniaPreventionProceduresProcessProteomicsProtocols documentationPublicationsRecruitment ActivityResearch PersonnelSamplingSepsisSpecimenStructureTechniquesTestingTraumaUnited States National Institutes of HealthWorkdrug testingimprovedinnovationmembermicrobiomemortalitynoveloperationpreventprotocol developmentpublic health relevance
项目摘要
DESCRIPTION (provided by applicant): The objective of this proposal is to support the operation of the NIH NHLBI prevention and early treatment of acute lung injury (PETAL) Network> The Network's goal is to efficiently test drugs, devices, and protocols to prevent and treat early acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) thereby improving the short and long-term outcomes of patients. To achieve this goal the investigators will:
1. Provide organizational leadership to a Steering Committee and Subcommittees to establish an orderly, rational, process to develop, select, and conduct at least two clinical trials and to refine the Network's structure, and operating procedures.
2. Collaborate in the generation of hypotheses, development of protocols, and refinement of recruitment and data collection techniques and methods to acquire and analyze clinical data and samples. This effort will include collection of high quality biological and genetic specimens to allow Network members and others outside the network to study the genomics, proteomics and microbiome of acute lung injury.
3. Over 5.5 years recruit a minimum of 220, gender and ethnically representative subjects to clinical trials to generate quality data to test hypotheses posed by the Steering Committee.
4. Disseminate study results through high profile scientific publications and presentations.
描述(由申请人提供):本提案的目的是支持 NIH NHLBI 急性肺损伤预防和早期治疗 (PETAL) 网络的运行> 该网络的目标是有效测试预防和治疗早期急性肺损伤 (ALI) 和急性呼吸窘迫综合征 (ARDS) 的药物、设备和方案,从而改善患者的短期和长期结果。为了实现这一目标,研究人员将:
1. 为指导委员会和小组委员会提供组织领导,以建立有序、合理的流程来开发、选择和进行至少两项临床试验,并完善网络的结构和操作程序。
2. 协作提出假设、制定方案以及完善招募和数据收集技术和方法,以获取和分析临床数据和样本。这项工作将包括收集高质量的生物和遗传样本,以便网络成员和网络外的其他人能够研究急性肺损伤的基因组学、蛋白质组学和微生物组。
3. 在 5.5 年内招募至少 220 名具有性别和种族代表性的受试者参加临床试验,以生成高质量数据来检验指导委员会提出的假设。
4. 通过高调的科学出版物和演示传播研究结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ARTHUR P WHEELER其他文献
ARTHUR P WHEELER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ARTHUR P WHEELER', 18)}}的其他基金
A Model-integrated, Guideline-driven Process Management System for Sepsis
模型集成、指南驱动的脓毒症流程管理系统
- 批准号:
7819433 - 财政年份:2009
- 资助金额:
$ 14.71万 - 项目类别:
A Model-integrated, Guideline-driven Process Management System for Sepsis
模型集成、指南驱动的脓毒症流程管理系统
- 批准号:
7937009 - 财政年份:2009
- 资助金额:
$ 14.71万 - 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8020428 - 财政年份:2005
- 资助金额:
$ 14.71万 - 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8429017 - 财政年份:2005
- 资助金额:
$ 14.71万 - 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
- 批准号:
8328472 - 财政年份:2005
- 资助金额:
$ 14.71万 - 项目类别:
OXIDANT STRESS AND CYTOKINES IN ENDOTOXIN INDUCED INJURY IN SHEEP
绵羊内毒素损伤中的氧化应激和细胞因子
- 批准号:
6109482 - 财政年份:1997
- 资助金额:
$ 14.71万 - 项目类别:
OXIDANT STRESS AND CYTOKINES IN ENDOTOXIN INDUCED INJURY IN SHEEP
绵羊内毒素损伤中的氧化应激和细胞因子
- 批准号:
6241605 - 财政年份:1996
- 资助金额:
$ 14.71万 - 项目类别:
CCTG CLINICAL NETWORK FOR ARDS TREATMENT--CRITICAL CARE
CCTG ARDS 治疗临床网络——重症监护
- 批准号:
2831373 - 财政年份:1994
- 资助金额:
$ 14.71万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
Roles of N-glycans on neutrophil beta2 integrins in progression of acute lung injury
N-聚糖对中性粒细胞β2整合素在急性肺损伤进展中的作用
- 批准号:
10837431 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别: